NORCROSS, Ga., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the scientific ...
NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday. The Boston-based company announced preclinical data for its novel “G-Protein-Coupled Receptor 119 ...
(Reuters) -Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said ...
A six-year-old boy was left with a ruptured liver after a woman flied off a slide at a water park and crashed into him. CCTV footage shows the child's father ignoring warnings from staff and swimming ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results